AdAlta Limited
ASX: 1AD.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Timothy Charles Oldham
- Employees
- 9
- Headquarters
- Melbourne, Australia
- IPO year
- 2016
- Market cap
- A$3.0M
- Website
- https://adalta.com.au
Loading 1AD…
Loading profile data…Frequently asked questions about 1AD
What does AdAlta Limited (1AD.AX) do?
AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has collaborative partnerships with GE Healthcare to dis...
Where does 1AD.AX trade?
AdAlta Limited (1AD.AX) trades on the Australian Securities Exchange.
What sector is 1AD.AX in?
AdAlta Limited (1AD.AX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of AdAlta Limited?
Timothy Charles Oldham is the chief executive officer of AdAlta Limited (1AD.AX).
Where is AdAlta Limited headquartered?
AdAlta Limited is headquartered in Australia.
Does 1AD.AX pay a dividend?
AdAlta Limited (1AD.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 1AD.AX go public?
AdAlta Limited (1AD.AX) completed its initial public offering in 2016.